Massachusetts General Hospital researchers and colleagues have developed a high-throughput screening method to test the toxicity of nanomaterials.

A robotic system (similar to that used for drug screening) puts nanoparticles inside tiny wells on a plate containing hundreds of separate wells. Each well contains one cell type. The system detects changes in the cells’ metabolism in response to the nanomaterial.